Generic Name and Formulations:
Cyclopentolate HCl 0.5%, 1%, 2%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for CYCLOGYL:
To produce mydriasis and cycloplegia.
Instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat in 5–10 minutes if necessary. Apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Small infants: instill 1 drop of 0.5% in the eye; apply pressure over nasolacrimal sac for 2–3 minutes, observe closely for 30 minutes. Children: instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat 5–10 minutes later with 0.5% or 1% solution if necessary; apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Untreated narrow-angle glaucoma or when untreated anatomically narrow angles are present.
Down's syndrome. Angle-closure glaucoma. Feeding intolerance in infants; withhold feeding for 4 hours after examination. Pregnancy (Cat.C). Nursing mothers.
May interfere with antihypertensive action of carbachol, pilocarpine, ophthalmic cholinesterase inhibitors.
Ocular effects (eg, increased intraocular pressure, burning, photophobia, blurred vision, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae); CNS disturbances (esp. in children).
Soln 0.5%—15mL; 1%, 2%—2mL, 5mL, 15mL